Jiangsu Yuyue Medical Equipment & Supply (002223) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue reached RMB 2.44 billion, up 9.17% year-over-year; net profit attributable to shareholders was RMB 625 million, down 5.26% year-over-year.

• Adjusted net profit (excluding non-recurring items) was RMB 513 million, down 6.91% year-over-year.

• Operating cash flow was RMB 658 million, down 2.64% year-over-year.

Financial highlights

• Total assets at quarter-end were RMB 16.42 billion, up 4.93% from year-end 2024.

• Shareholders' equity was RMB 13.11 billion, up 4.56% from year-end 2024.

• Basic and diluted EPS were both RMB 0.6271, down 5.26% year-over-year.

• Gross margin and operating margin details not specified, but sales expenses rose 32.67% year-over-year.

Outlook and guidance

• No explicit forward guidance, but ongoing product innovation and international expansion highlighted.